Projects & Credentials

Recent Projects

    Transaction Projects

  • International Nasdaq listed pharmaceutical company

    • Licensing BU cardiovascular to Big Pharma (deal volume > 2mn USD)

  • German Startup from Medical School Hannover (MHH)

    • Series A financing round 15 mn EUR: Syndicate from 5 Top Tier international investors incl. Big Pharma

  • German Start-up from University Heidelberg

    • 6 months after incorporation: trade sale & merger integration to Dutch biopharma-ceutical company volume > 20 mn EUR

  • German Biotech company

    • Seed, Series A and IPO at Frankfurt Stock Exchange (in total 30 mn EUR raised)

  • German biotech Cluster

    • Support in a grant submission, 40 mn EUR raised

  • German Start-Up white biotech

    • Business model and planning, incorporation, trade sale to US pharma company

  • German Start-Up from Charité Berlin

    • Seed financing about 2 mn EUR including 500 kEUR public grant

    Strategy projects

  • International pharma company (Rx, Gx, OTC, turnover >20bn EUR)

    • Subject Matter Expert for growth strategy by M&A in OTC market Germany

  • Leading German family business in the area of sterile filling

    • Growth strategy by establishing new busi- ness unit biotechnology

  • German listed pharma and laboratory supplier (turnover >1bn EUR)

    • Market analysis for exploring new business area dedicated to cell based products

  • Leading East European pharma company (turnover >1,5bn EUR)

    • Strategic portfolio review and market analysis for business unit biotechnology / biosimilars

  • Joint Venture German chemistry holding / biotech venture

    • Market analysis and growth strategy in R&D

  • German medtech company / family owned

    • Growth & innovation strategy including market analysis and business planning

  • Scandinavian SME providing cosmetic products

    • Market entry consulting

  • French OTC business (eye/ nose/ throat diseases)

    • Market research and access consulting/ partnering

  • German/Austrian developer and manufacturer of medical devices

    • Implementation of new strategy incl. development of corporate culture

  • International machine manufacturer

    • Qualification of managers and staff accord- ing to new strategy and improvement of market position



ulbrich&partner management consulting
Claudia Ulbrich MD
Güntherstraße 7A | 30519 Hannover | Germany | Mobile +49 (0) 172 / 455 76 32
Phone +49 (0) 511 / 37 48 40 51
Geschäftsführung: Dr. Claudia Ulbrich

1. Content
The author reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected. All offers are not-binding and without obligation. Parts of the pages or the complete publication including all offers and information might be extended, changed or partly or completely deleted by the author without separate announcement.

2. Referrals and links
The author is not responsible for any contents linked or referred to from his pages - unless he has full knowledge of illegal contents and would be able to prevent the visitors of his site from viewing those pages. If any damage occurs by the use of information presented there, only the author of the respective pages might be liable, not the one who has linked to these pages. Furthermore the author is not liable for any postings or messages published by users of discussion boards, guestbooks or mailing lists provided on his page.

3. Copyright
The author intended not to use any copyrighted material for the publication or, if not possible, to indicate the copyright of the respective object. The copyright for any material created by the author is reserved. Any duplication or use of objects such as images, diagrams, sounds or texts in other electronic or printed publications is not permitted without the author's agreement.

4. Privacy policy
If the opportunity for the input of personal or business data (email addresses, name, addresses) is given, the input of these data takes place voluntarily. The use and payment of all offered services are permitted - if and so far technically possible and reasonable - without specification of any personal data or under specification of anonymized data or an alias. The use of published postal addresses, telephone or fax numbers and email addresses for marketing purposes is prohibited, offenders sending unwanted spam messages will be punished.

5. Legal validity of this disclaimer
This disclaimer is to be regarded as part of the internet publication which you were referred from. If sections or individual terms of this statement are not legal or correct, the content or validity of the other parts remain uninfluenced by this fact.